PHT Corporation, the leading provider of technologies used to collect patient-driven eData for clinical research, has completed self-certification of compliance with the Safe Harbor Framework.
The U.S.-EU Safe Harbor Framework and the U.S.-Swiss Safe Harbor Framework established seven principles for collection, use, disclosure and retention of personal information from European Union member countries and Switzerland. PHT engaged third parties, Wagner Law Group and Security Best Practices, to review its privacy policies and processes for compliance with Safe Harbor. Following the review, the Company filed its self-certification that was accepted on 25 September 2014.
Find the PHT Safe Harbor Privacy Policy Statement here: http://www.phtcorp.com/Safe-Harbor.aspx
Dr. Stephen Raymond, PHT Chief Scientific, Quality and Privacy Officer, explained the policy: “PHT places the highest importance on the privacy and security of our client data. Completing the Safe Harbor privacy framework certification process formalizes PHT’s rigorous privacy and security principles for all the personal information under our care as we continue driving the adoption of eCOA systems and services to improve clinical research worldwide.”
PHT upholds high ethical standards in its business practices and strives to collect, maintain, use and disclose the information collected during patient clinical trials and human resources information for PHT employees in the EU and Switzerland in a manner consistent with the laws of the countries in which it does business.
View PHT certification and learn more about Safe Harbor certification: http://www.export.gov/safeharbor
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 675+ trials resulting in 21+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.
